Keryx Biopharmaceuticals (KERX) Files To Offer $40M In Stock and Warrants
Tweet Send to a Friend
Keryx Biopharmaceuticals (Nasdaq: KERX), which jumped over 20% today on positive trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
